معرفی
Nicholas La Thangue is a Professor of Cancer Biology at the University of Oxford's Department of Oncology and a Professorial Fellow at Linacre College. Previously, he served as Cathcart Professor of Biochemistry at the University of Glasgow and as a scientist at the Medical Research Council. His research focuses on the molecular mechanisms underlying tumour cell proliferation.
- Fellow of the Royal Society of Edinburgh
- EMBO Member
- Fellow of the Academy of Medical Sciences
- Fellow of the European Academy of Cancer Sciences
- Fellow of the Lister Institute
- Founder of Oxford Cancer Biomarkers
Recent publications highlight his work in RNA splicing regulation (e.g., PRMT5 in neuroblastoma), post-translational modification crosstalk (e.g., citrullination in cancer), immunogenic peptides from non-coding RNAs, HDAC inhibitor effects on immunity, and clinical trials in colorectal cancer. His research spans genome integrity, epigenetics, and translational oncology.
- Scientific advisor to the European Commission's Horizon 202202 program
- Collaborator with institutions in the Netherlands, Texas, and Germany
The La Thangue Group at Oxford includes postdoctoral researchers like Laurel Bate-Eya and Simon Carr, as well as visiting scientists and DPhil students. Alumni such as Heidi Olzscha and Rebecca Miller have transitioned to academic roles in Germany and Denmark.
